TrialPloS one2019

Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study.

Satoshi Motoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.